In addition, it has been reported that pancreatic tumors harboring p53 mutations promote CAF reprogramming toward a prometastatic subset with the secretion of heparin sulfate proteoglycan 2 (HSPG2) in the stroma. Here, TP53 is linked to pancreatic neoplasm.